Skip to main content
Premium Trial:

Request an Annual Quote

KineMed Licenses GeneGo Software for Leukemia Study

NEW YORK (GenomeWeb News) – KineMed has licensed GeneGo’s MetaCore software for an ongoing Phase II prognostic study of chronic lymphocytic leukemia, GeneGo said today.
 
KineMed is testing a biomarker of CLL flux as a predictor of disease course that is intended to stratify indolent versus aggressive disease.
 
MetaCore is GeneGo’s flagship product and is used for target selection and validation, identification of biomarkers for disease states, and toxicology.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.